BridgeBio Oncology Therapeutics (BBOT)
Uneek Mehra currently serves as Chief Financial Officer at BBOT since July 2025 and as Chief Financial and Business Officer (Advisor) at 4D Molecular Therapeutics since September 2023. Previously, Mehra held the position of Chief Financial and Business Officer at Myovant Sciences from September 2021 to July 2023, and served as Chief Financial Officer at PACT Pharma from October 2019 to September 2021. Prior to that, Mehra was EVP & Chief Financial Officer at Proteus Digital Health, Inc from April 2017 to October 2019. Educational qualifications include an MBA in Leadership & Business Strategy from IMD and an MBA in Finance & Systems from the University of Mumbai.
This person is not in any teams
This person is not in any offices
BridgeBio Oncology Therapeutics (BBOT)
BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio, BridgeBio Oncology Therapeutics completed a $200M private financing with external investors in 2024 with the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors.